ARTRYA Ltd (AYA) - Total Liabilities
Based on the latest financial reports, ARTRYA Ltd (AYA) has total liabilities worth AU$2.84 Million AUD (≈ $2.01 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore AYA net asset momentum to track the company's year-over-year net asset growth rate.
ARTRYA Ltd - Total Liabilities Trend (2019–2025)
This chart illustrates how ARTRYA Ltd's total liabilities have evolved over time, based on quarterly financial data.
ARTRYA Ltd Competitors by Total Liabilities
The table below lists competitors of ARTRYA Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tecnon Fujian Commercial Lighting Co Ltd
SHE:300650
|
China | CN¥941.87 Million |
|
RattanIndia Enterprises Limited
NSE:RTNINDIA
|
India | Rs22.46 Billion |
|
Peet Ltd
AU:PPC
|
Australia | AU$403.77 Million |
|
Longjian Road & Bridge Co Ltd
SHG:600853
|
China | CN¥30.42 Billion |
|
Zhejiang Netsun Co Ltd
SHE:002095
|
China | CN¥410.56 Million |
|
SECHE ENVIRO.UNSP.ADR 1/5
F:SCB0
|
Germany | €1.67 Billion |
|
Richtech Robotics Inc. Class B Common Stock
NASDAQ:RR
|
USA | $9.74 Million |
|
Infund Holding Co Ltd
SHE:002141
|
China | CN¥361.20 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down ARTRYA Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ARTRYA Ltd (AYA) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 37.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ARTRYA Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ARTRYA Ltd (2019–2025)
The table below shows the annual total liabilities of ARTRYA Ltd from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$2.39 Million ≈ $1.69 Million |
+8.11% |
| 2024-06-30 | AU$2.21 Million ≈ $1.56 Million |
-12.80% |
| 2023-06-30 | AU$2.53 Million ≈ $1.79 Million |
-21.59% |
| 2022-06-30 | AU$3.23 Million ≈ $2.28 Million |
+175.98% |
| 2021-06-30 | AU$1.17 Million ≈ $827.85K |
+620.51% |
| 2020-06-30 | AU$162.39K ≈ $114.90K |
+163.73% |
| 2019-06-30 | AU$61.57K ≈ $43.57K |
-- |
About ARTRYA Ltd
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography sca… Read more